. Author manuscript; available in PMC: 2018 Jan 18.

Published in final edited form as: Ann Surg Oncol. 2011 Jun 17;18(13):3544–3550. doi: 10.1245/s10434-011-1818-9

Table 4.

Study sizes and race/ethnicity distributions for protocols evaluated in this report.

Organ Site	Study ID	Total Accrual	Race-Ethnicity Distribution N (%)^*			Accrual “Success”
Organ Site	Study ID	Total Accrual	WA	AA	HA	AA	HA
Breast	Z0010	5539	4814 (87%)	420 (8%)	127 (2%)	modestly successful	unsuccessful
Breast	Z0011	891	732 (82%)	86 (10%)	42 (5%)	modestly successful	successful
Breast	Z1031	377	304 (81%)	55 (15%)	48 (13%)	successful	successful
Sarcoma	Z9000	109	89 (82%)	9 (8%)	2 (2%)	modestly successful	unsuccessful
Sarcoma	Z9001	778	615 (79%)	97 (12%)	34 (4%)	successful	unsuccessful
Thoracic	Z0030	1111	1037(93%)	49(4%)	4 (0.4%)	unsuccessful	unsuccessful
Thoracic	Z0040	1310	1201 (92%)	73 (6%)	12 (0.9%)	modestly successful	unsuccessful
Thoracic	Z0050	445	401 (90%)	36 (8%)	2 (0.4%)	modestly successful	unsuccessful
Thoracic	Z0060	262	243 (93%)	11 (4%)	2 (0.8%)	unsuccessful	unsuccessful
Thoracic	Z4031	1073	981 (91%)	69 (6%)	6 (0.6%)	modestly successful	unsuccessful

differences between summation of reported race/ethnicities and total accrual population are participants self-recorded as either “Asian American”; “Other” or race-ethnicity “Unknown”.